These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 34870700)

  • 41. Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis.
    Marques ARA; Di Spiezio A; Thießen N; Schmidt L; Grötzinger J; Lüllmann-Rauch R; Damme M; Storck SE; Pietrzik CU; Fogh J; Bär J; Mikhaylova M; Glatzel M; Bassal M; Bartsch U; Saftig P
    Autophagy; 2020 May; 16(5):811-825. PubMed ID: 31282275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secretion and function of Cln5 during the early stages of Dictyostelium development.
    Huber RJ; Mathavarajah S
    Biochim Biophys Acta Mol Cell Res; 2018 Jul; 1865(10):1437-1450. PubMed ID: 30048658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease.
    Morgan JP; Magee H; Wong A; Nelson T; Koch B; Cooper JD; Weimer JM
    PLoS One; 2013; 8(11):e78694. PubMed ID: 24223841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuronal ceroid lipofuscinosis (NCL) is caused by the entire deletion of CLN8 in the Alpenländische Dachsbracke dog.
    Hirz M; Drögemüller M; Schänzer A; Jagannathan V; Dietschi E; Goebel HH; Hecht W; Laubner S; Schmidt MJ; Steffen F; Hilbe M; Köhler K; Drögemüller C; Herden C
    Mol Genet Metab; 2017 Mar; 120(3):269-277. PubMed ID: 28024876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Batten disease: four genes and still counting.
    Mole SE
    Neurobiol Dis; 1998 Nov; 5(5):287-303. PubMed ID: 10069573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Batten disease (Neuronal ceroid lipofuscinoses)--accumulation of ATP synthase subunit c caused by the delay of lysosomal degradation].
    Ezaki J; Kominami E
    Nihon Rinsho; 1995 Dec; 53(12):3055-61. PubMed ID: 8577058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses.
    Warrier V; Vieira M; Mole SE
    Biochim Biophys Acta; 2013 Nov; 1832(11):1827-30. PubMed ID: 23542453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experimental gene therapies for the NCLs.
    Liu W; Kleine-Holthaus SM; Herranz-Martin S; Aristorena M; Mole SE; Smith AJ; Ali RR; Rahim AA
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165772. PubMed ID: 32220628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins.
    Kyttälä A; Lahtinen U; Braulke T; Hofmann SL
    Biochim Biophys Acta; 2006 Oct; 1762(10):920-33. PubMed ID: 16839750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The intracellular location and function of proteins of neuronal ceroid lipofuscinoses.
    Ezaki J; Kominami E
    Brain Pathol; 2004 Jan; 14(1):77-85. PubMed ID: 14997940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neonatal brain-directed gene therapy rescues a mouse model of neurodegenerative CLN6 Batten disease.
    Kleine Holthaus SM; Herranz-Martin S; Massaro G; Aristorena M; Hoke J; Hughes MP; Maswood R; Semenyuk O; Basche M; Shah AZ; Klaska IP; Smith AJ; Mole SE; Rahim AA; Ali RR
    Hum Mol Genet; 2019 Dec; 28(23):3867-3879. PubMed ID: 31807779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induced Pluripotent Stem Cells Derived from a CLN5 Patient Manifest Phenotypic Characteristics of Neuronal Ceroid Lipofuscinoses.
    Uusi-Rauva K; Blom T; von Schantz-Fant C; Blom T; Jalanko A; Kyttälä A
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis.
    Geraets RD; Koh Sy; Hastings ML; Kielian T; Pearce DA; Weimer JM
    Orphanet J Rare Dis; 2016 Apr; 11():40. PubMed ID: 27083890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration.
    Tyynelä J; Sohar I; Sleat DE; Gin RM; Donnelly RJ; Baumann M; Haltia M; Lobel P
    EMBO J; 2000 Jun; 19(12):2786-92. PubMed ID: 10856224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravitreal gene therapy protects against retinal dysfunction and degeneration in sheep with CLN5 Batten disease.
    Murray SJ; Russell KN; Melzer TR; Gray SJ; Heap SJ; Palmer DN; Mitchell NL
    Exp Eye Res; 2021 Jun; 207():108600. PubMed ID: 33930398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses.
    Kida E; Golabek AA; Wisniewski KE
    Adv Genet; 2001; 45():35-68. PubMed ID: 11332776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant adhesion impacts early development in a Dictyostelium model for juvenile neuronal ceroid lipofuscinosis.
    Huber RJ; Myre MA; Cotman SL
    Cell Adh Migr; 2017 Jul; 11(4):399-418. PubMed ID: 27669405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of Brain and Cerebrospinal Fluid from Mouse Models of the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Changes in the Lysosomal Proteome.
    Sleat DE; Wiseman JA; El-Banna M; Zheng H; Zhao C; Soherwardy A; Moore DF; Lobel P
    Mol Cell Proteomics; 2019 Nov; 18(11):2244-2261. PubMed ID: 31501224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic oral administration of minocycline to sheep with ovine CLN6 neuronal ceroid lipofuscinosis maintains pharmacological concentrations in the brain but does not suppress neuroinflammation or disease progression.
    Kay GW; Palmer DN
    J Neuroinflammation; 2013 Jul; 10():97. PubMed ID: 23899308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease).
    Kay GW; Verbeek MM; Furlong JM; Willemsen MA; Palmer DN
    Neurochem Int; 2009 Dec; 55(8):783-8. PubMed ID: 19664668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.